Berg, Hege F. http://orcid.org/0000-0002-1712-6609
Engerud, Hilde
Myrvold, Madeleine
Lien, Hilde E.
Hjelmeland, Marta Espevold
Halle, Mari K. http://orcid.org/0000-0002-2660-8271
Woie, Kathrine
Hoivik, Erling A. http://orcid.org/0000-0003-0680-765X
Haldorsen, Ingfrid S.
Vintermyr, Olav
Trovik, Jone
Krakstad, Camilla http://orcid.org/0000-0002-0174-8139
Funding for this research was provided by:
Helse Vest (F-12542)
Article History
Received: 24 January 2022
Revised: 3 November 2022
Accepted: 9 November 2022
First Online: 8 December 2022
Ethics approval and consent to participate
: This study was approved by the Regional Committee for Medical and Health Research Ethics (REK 2009/2315, 2018/594), according to Norwegian legislation and regulation. The patient tumour samples were provided by the Gynaecologic Cancer Biobank (REK 2014/1907), Women’s Clinic, Haukeland University Hospital, Bergen, Norway. All participants gave written informed consent prior to inclusion.
: Not applicable.
: The authors declare no competing interests.